Compounded Tirzepatide Cost (2026)

Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research

Free comparison

Compare GLP-1 providers & cash-pay options

See telehealth and pharmacy programs that may lower your monthly cost.

MetaDose may earn a fee through partner links. See our disclaimer.

Compounded tirzepatide typically advertises $250–$450/month versus $1,000+ brand Mounjaro or Zepbound cash. Demand spiked during brand shortages; as shortages ease, some compounders tighten eligibility. Price is only half the decision — dose consistency and pharmacy registration matter as much as the sticker.

Price stack vs brand

Use Truth Checker to add labs/shipping; use Drug Matrix to see brand list for your state.

  • Compounded membership (meds + consult claimed): $250–$450/mo
  • Brand cash Zepbound/Mounjaro: ~$1,000–$1,200/mo
  • Brand + commercial card: often $25–$100/mo if covered — Mounjaro vs Zepbound
  • Molecule comparison economics: semaglutide vs tirzepatide cost

Due diligence before switching

Ask which pharmacy compounds the product, whether it is 503A or 503B, and how dose increases are billed. If your insurer later covers Zepbound, plan a supervised transition rather than mixing sources.

GLP-1 cost by state

Frequently Asked Questions

Why is compounded tirzepatide cheaper?

Different supply chain and regulatory path — not brand device economics. Quality and consistency vary by pharmacy.

Related tools & pages

More GLP-1 guides

View all 39 guides →